Month: July 2022

MONTREAL, July 04, 2022 (GLOBE NEWSWIRE) — HPQ Silicon Resources Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQX: HPQFF) (FWB: UGE), an innovative silicon solutions and technology development company, is pleased to announce the voting results from its annual meeting of shareholders held on June 30, 2022. A total of approximately 26% of the issued and outstanding common shares of HPQ were represented at the meeting. All of the nominees for election as directors of HPQ referred to in its management information circular for the meeting were elected. Votes cast on this matter were as follows:Nominees Votes For % of Votes For Votes Withheld % of VotesWithheldBernard J. Tourillon 82,696,914 99.61% 327,357 0.39%Noelle Drapeau 82,510,129 99.38% 514,142 0.62%Patrick Levasseur 82,569,144 99.45% 455,127 0.55%Robert Robitaille 82,714,041 99.63% 310,230 0.37%Richard...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Oslo, 4 July 2022 Interoil Exploration and Production ASA (the “Company”) refers to its previous announcements regarding the Company’s ongoing share issue with gross proceeds of up to NOK 30 million at a price per share of NOK 1.30 (the “Share Issue”). The Company’s Board of Directors has resolved to allocate and issue a total of 15,201,296 shares in the Share Issue at a subscription price of NOK 1.30 per share, resulting in total gross proceeds of NOK 19,761,684.80 to the Company. Notifications of allocation will be distributed to applicants on or about 5 July 2022. The...

In week 27 2022 Eimskip purchased 64,257 of its own shares, at a purchase price of ISK 29,636,734 as further stipulated below:Date Time No. of shares Share price Purchase price4.7.2022 12:57:56 50,000 461 23,050,0004.7.2022 14:15:20 14,257 462 6,586,734Total   64,257   29,636,734The trade is in accordance with Eimskip‘s buy-back program as published on Nasdaq Iceland on 30 May 2022. The repurchase according to the share buy-back program is completed. Eimskip held 1,697,050 own shares prior to the notified transactions, and holds 1,761,307 shares after them, or the equivalent of 1,02% of issued shares in the company. Under the buy-back program Eimskip purchased a total of 1,730,000 shares in the company amounting to ISK 830,681,659 market value. Buy-back under the program would amount to a maximum of 1,730,000 shares and...

Inventiva successfully raised approximately €14.6 million through a combination of its ATM Program for €9.3 million and new State-backed bank financing for €5.3 million In accordance with the terms of the credit facility announced on May 16, 2022, Inventiva entered into a warrant agreement with the European Investment Bank on July 1, 2022 Cash runway extended until the end of second quarter 2023Daix (France), Long Island City (New York, United States), July 4, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepatitis (NASH) and other diseases with significant unmet medical needs, today announced the strengthening of its cash position by approximately €14.6 million...

REGULATED INFORMATION LIQUIDITY CONTRACT Half-year liquidity contract statement for BOUYGUES Under the liquidity contract entered into between BOUYGUES and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2022: –     333,558 shares–     € 12,375,775.69Number of executions on buy side on semester: 5,538 Number of executions on sell side on semester: 5,600 Traded volume on buy side on semester: 3,772,636 shares for € 119,070,307.03 Traded volume on sell side on semester: 3,652,020 shares for € 116,247,902.27As a reminder :the following resources appeared on the last half year statement on 31 December 2021 on the liquidity account:–     212,942 shares–     € 15,242,298.97Number of executions on buy side on semester: 1,857 Number of executions on sell side on semester:...

  During the period between June 27 – July 1, 2022 Bilia AB (LEI code 2138002GW5WN1UYZA032) has repurchased in total 117,597 own shares (ISIN SE0009921588 ) as part of the buyback program initiated by the Board of Directors in order to optimize the company’s capital structure. The buyback program, which began on June 1, 2022, is hereby completed as a total of 674,000 shares for a total amount of SEK 99,940,393 have been repurchased. The share buybacks below formed a part of the buyback program of a maximum of 800,000 shares for a total maximum amount of SEK 100 M, which Bilia AB announced on May 10, 2022. The buyback program, has been carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (”MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the ”Safe Harbour Regulation”). The objective of the share buybacks...

The report of Festi´s nomination comittee to the shareholders meeting which will take place on 14 July 2022 is attached.AttachmentFesti – skýrsla tilnefningarnefndar 4. júlí 2022

PRESS RELEASEJuly 4, 2022HALF-YEARLY ACHIEVEMENT REPORT ON KERING SHAREQUOTATIONS LIQUIDITY MANDATE Pursuant to the liquidity mandate granted by Kering to Rothschild Martin Maurel, the following assets appeared on the liquidity account as of June 30th, 2022:750 shares €24,495,035Number of executions on buy side during the semester: 7,074Number of executions on sell side during the semester: 6,319Traded volume on buy side during the semester: 100,509 shares for 55,299,020.67 €Traded volume on sell side during the semester: 99,759 shares for 55,004,097.52 € As a reminder, the following assets appeared on the liquidity account as of December 31st, 2021:0 share €24,867,017Number of executions on buy side during the semester: 2,172Number of executions on sell side during the semester: 2,360Traded volume on buy side during the...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 04, 2022 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) is pleased to announce the closing of its previously announced marketed public offering of units of the Company (the “Units” or the “Offered Securities”) with Research Capital Corporation as the sole agent and sole bookrunner (the “Agent”). Pursuant to the offering, the Company issued 309,117 Units at a price of $3.75 per Unit for gross proceeds of $1,159,188.75 (the “Offering”). Each Unit consists of one Class A common share of the Company (a “Common Share“) and one Common Share purchase warrant of the Company (a “Warrant“). Each Warrant entitles the holder...